The role of postoperative radiotherapy for stage I/II/III thymic tumor-results of the ChART retrospective database.

BACKGROUND Postoperative radiotherapy (PORT) for thymic tumor is still controversial. The object of the study is to evaluate the role of PORT for stage I to III thymic tumors. METHODS The Chinese Alliance for Research in Thymomas (ChART) was searched for patients with stage I to III thymic tumors who underwent surgical resection without neoajuvant therapy between 1994 and 2012. Univariate and multivariate survival analyses were performed. Cox proportional hazard model was used to determine the hazard ratio for death. RESULT From the ChART database, 1,546 stage I to III patients were identified. Among these patients, 649 (41.98%) received PORT. PORT was associated with gender, histological type (World Health Organization, WHO), thymectomy extent, resection status, Masaoka-Koga stage and adjuvant chemotherapy. The 5-year and 10-year overall survival (OS) rates and disease-free survival (DFS) rates for patients underwent surgery followed by PORT were 90% and 80%, 81% and 63%, comparing with 96% and 95%, 92% and 90% for patients underwent surgery alone (P=0.001, P<0.001) respectively. In univariate analysis, age, histological type (WHO), Masaoka-Koga stage, completeness of resection, and PORT were associated with OS. Multivariable analysis showed that histological type (WHO) (P=0.001), Masaoka-Koga stage (P=0.029) and completeness of resection (P=0.003) were independently prognostic factors of OS. In univariate analysis, gender, myasthenia gravis, histological subtype, Masaoka-Koga stage, surgical approach, PORT and completeness of resection were associated with DFS. Multivariate analysis showed that histological subtype (P<0.001), Masaoka-Koga stage (P=0.005) and completeness of resection (P=0.006) were independent prognostic factors for DFS. Subgroup analysis showed that patients with incomplete resection underwent PORT achieved better OS and DFS (P=0.010, 0.017, respectively). However, patients with complete resection underwent PORT had the worse OS and DFS (P<0.001, P<0.001, respectively). CONCLUSIONS The current retrospective study indicates that PORT after incomplete resection could improve OS and DFS for patients with stage I to III thymic tumors. However for those after complete resection, PORT does not seem to have any survival benefit on the whole.

[1]  N. Ikeda,et al.  Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II and III thymic epithelial tumors: The Japanese Association for Research on the Thymus Database Study , 2015, Cancer.

[2]  F. Detterbeck,et al.  胸腺肿瘤预后因素的现状 , 2014, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[3]  F. Detterbeck,et al.  Thymoma: current diagnosis and treatment , 2013, Chinese medical journal.

[4]  A. Pennathur,et al.  The role of adjuvant radiation therapy for resected stage III thymoma: a population-based study. , 2012, The Annals of thoracic surgery.

[5]  E. Engels Epidemiology of Thymoma and Associated Malignancies , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[6]  Y. Yoshioka,et al.  Postoperative radiation therapy after complete resection of thymoma has little impact on survival , 2009, Cancer.

[7]  A. Bezjak,et al.  The Management of Thymoma: A Systematic Review and Practice Guideline , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[8]  Stefan Fischer,et al.  Thymomas: review of current clinical practice. , 2009, The Annals of thoracic surgery.

[9]  P. Christos,et al.  Adjuvant radiotherapy for thymic epithelial tumors: a systematic review and meta-analysis. , 2009, The Annals of thoracic surgery.

[10]  M. Levitt,et al.  Adjuvant Radiotherapy for Thymic Epithelial Tumor: Treatment Results and Prognostic Factors , 2007, American journal of clinical oncology.

[11]  E. Ruffini,et al.  World Health Organization histologic classification: an independent prognostic factor in resected thymomas. , 2005, Lung cancer.

[12]  C. Angeletti,et al.  Advanced stage thymomas and thymic carcinomas: results of multimodality treatments. , 2005, The Annals of thoracic surgery.

[13]  J. Wain,et al.  Adjuvant radiation of stage III thymoma: is it necessary? , 2005, The Annals of thoracic surgery.

[14]  S. Lipsitz,et al.  Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  F. Rea,et al.  Long-term survival and prognostic factors in thymic epithelial tumours. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[16]  K. Kondo,et al.  Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. , 2003, The Annals of thoracic surgery.

[17]  A. Marx,et al.  New WHO histologic classification predicts prognosis of thymic epithelial tumors , 2002, Cancer.

[18]  H. Onishi,et al.  Postoperative radiotherapy for patients with completely resected thymoma , 2002, Cancer.

[19]  J. Morgan,et al.  Pericardial mesothelioma following mantle field radiotherapy. , 2001, The Journal of cardiovascular surgery.

[20]  Charles R. Thomas,et al.  Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma , 2001, Cancer.

[21]  N. Harris,et al.  Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study. , 2000, International journal of radiation oncology, biology, physics.

[22]  S. Apter,et al.  Radiation pneumonitis complicating mediastinal radiotherapy postpneumonectomy. , 1996, The European respiratory journal.

[23]  R. Holloway,et al.  Effects of mediastinal irradiation on oesophageal function. , 1996, Gut.

[24]  C. L. Chen,et al.  Thymic carcinoma: Ten years' experience in twenty patients , 1994 .

[25]  S. Miyoshi,et al.  Thymoma: results with complete resection and adjuvant postoperative irradiation in 141 consecutive patients. , 1988, The Journal of thoracic and cardiovascular surgery.

[26]  David R. Jones,et al.  Thymic carcinoma outcomes and prognosis: results of an international analysis. , 2015, The Journal of thoracic and cardiovascular surgery.

[27]  A. Nicholson,et al.  [The Masaoka-Koga stage classification for thymic malignancies clarification and definition of terms]. , 2014, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[28]  Guifang Yang,et al.  Preoperative CT findings of thymoma are correlated with postoperative Masaoka clinical stage. , 2013, Academic radiology.

[29]  A. Pennathur,et al.  Thymic carcinoma: a multivariate analysis of factors predictive of survival in 290 patients. , 2013, The Annals of thoracic surgery.

[30]  F. Detterbeck,et al.  THYMIC TUMORS: A REVIEW OF CURRENT DIAGNOSIS, CLASSIFICATION, AND TREATMENT , 2008 .

[31]  K. Kondo,et al.  [Thymic carcinoma]. , 2002, Kyobu geka. The Japanese journal of thoracic surgery.

[32]  J. Denekamp,et al.  Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients. , 2000, International journal of radiation oncology, biology, physics.

[33]  E. Ruffini,et al.  Recurrence of thymoma: analysis of clinicopathologic features, treatment, and outcome. , 1997, The Journal of thoracic and cardiovascular surgery.

[34]  R. Cianci,et al.  [Thymoma: results of 241 operated cases]. , 1990, Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale.

[35]  C. Sundström Tumours of the thymus. , 1975, Upsala journal of medical sciences.